- Home
- ATAI vs ESRT Comparison
ATAI vs ESRT Comparison
Compare ATAI & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- ESRT
- Stock Information
- Founded
- ATAI 2018
- ESRT 2011
- Country
- ATAI Netherlands
- ESRT United States
- Employees
- ATAI N/A
- ESRT N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- ESRT Real Estate Investment Trusts
- Sector
- ATAI Health Care
- ESRT Real Estate
- Exchange
- ATAI Nasdaq
- ESRT Nasdaq
- Market Cap
- ATAI 1.1B
- ESRT 1.2B
- IPO Year
- ATAI 2021
- ESRT 2013
- Fundamental
- Price
- ATAI $5.88
- ESRT $7.23
- Analyst Decision
- ATAI Strong Buy
- ESRT Hold
- Analyst Count
- ATAI 5
- ESRT 2
- Target Price
- ATAI $14.00
- ESRT $10.65
- AVG Volume (30 Days)
- ATAI 7.1M
- ESRT 1.9M
- Earning Date
- ATAI 11-14-2025
- ESRT 10-29-2025
- Dividend Yield
- ATAI N/A
- ESRT 1.96%
- EPS Growth
- ATAI N/A
- ESRT N/A
- EPS
- ATAI N/A
- ESRT 0.24
- Revenue
- ATAI $2,309,000.00
- ESRT $763,282,000.00
- Revenue This Year
- ATAI $736.04
- ESRT $2.27
- Revenue Next Year
- ATAI N/A
- ESRT $3.04
- P/E Ratio
- ATAI N/A
- ESRT $29.93
- Revenue Growth
- ATAI 510.85
- ESRT 1.14
- 52 Week Low
- ATAI $1.04
- ESRT $6.56
- 52 Week High
- ATAI $6.75
- ESRT $11.43
- Technical
- Relative Strength Index (RSI)
- ATAI 52.01
- ESRT 38.77
- Support Level
- ATAI $5.50
- ESRT $7.10
- Resistance Level
- ATAI $6.23
- ESRT $8.04
- Average True Range (ATR)
- ATAI 0.46
- ESRT 0.23
- MACD
- ATAI -0.06
- ESRT -0.03
- Stochastic Oscillator
- ATAI 26.71
- ESRT 4.76
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.